Description
Research has indicated the following possible benefits:
Significant Weight Loss: Mazdutide has shown promising results in clinical trials, with a phase 1b study demonstrating a mean body weight reduction of up to 9.8% in participants receiving the highest doses. A phase 2 study reported up to a 15.4% reduction in body weight over 24 weeks.
Metabolic Benefits: Beyond weight loss, Mazdutide has been associated with improvements in blood pressure, lipid profiles, and liver enzyme levels. These benefits contribute to better management of type 2 diabetes and reduced cardiovascular risk.
Body Composition: Clinical trials have also shown reductions in waist circumference, body mass index (BMI), and liver fat content, indicating a positive impact on overall body composition and metabolic health.



